SCHEMBL7087977

SCHEMBL7087977

Nc1cccc(N/C(=C2\C(=O)Nc3ccc(N)cc32)c2ccccc2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 6/20 0.50
DDX3X O00571 1/20 0.41
ALDH1A1 P00352 2/20 0.40
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40
AKT1 P31749 1/20 0.39
AKT2 P31751 1/20 0.39
GSK3B P49841 3/20 0.38
TLK2 Q86UE8 2/20 0.38
PTGS1 P23219 1/20 0.38
JAK3 P52333 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7087980 1.00 PDPK1 (0.50) PDPK1DDX3XALDH1A1HDAC3HDAC4
SCHEMBL7086762 0.94 PDPK1 (0.45) PDPK1AKT1AKT2GSK3BTLK2
SCHEMBL7086761 0.94 PDPK1 (0.45) PDPK1AKT1AKT2GSK3BTLK2
SCHEMBL29643001 0.94 PDPK1 (0.45) PDPK1AKT1AKT2GSK3BTLK2
SCHEMBL7084766 0.92 PDPK1 (0.48) PDPK1AKT1AKT2GSK3BMAPT
SCHEMBL7089467 0.92 PDPK1 (0.46) PDPK1ALDH1A1AKT1AKT2GSK3B
SCHEMBL7084763 0.92 PDPK1 (0.48) PDPK1AKT1AKT2GSK3BMAPT
SCHEMBL7984608 0.92 PDPK1 (0.46) PDPK1ALDH1A1AKT1AKT2GSK3B
SCHEMBL6320960 0.92 PDPK1 (0.46) PDPK1DDX3XALDH1A1HDAC3HDAC4
SCHEMBL6320711 0.92 PDPK1 (0.46) PDPK1DDX3XALDH1A1HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1071665-B1 SUBSTITUTED INDOLINONES HAVING AN INHIBITING EFFECT ON KINASES AND CYCLINE/CDK COMPLEXES BOEHRINGER INGELHEIM PHARMA (DE) 2003-10-01 EP disclosed
EP-1071665-A1 SUBSTITUTED INDOLINONES HAVING AN INHIBITING EFFECT ON KINASES AND CYCLINE/CDK COMPLEXES Boehringer Ingelheim Pharma KG (DE) 2001-01-31 EP disclosed
US-6169106-B1 ANTITUMOUR AGENTS BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-01-02 US disclosed
WO-1999052869-A1 SUBSTITUTED INDOLINONES HAVING AN INHIBITING EFFECT ON KINASES AND CYCLINE/CDK COMPLEXES BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-10-21 WO disclosed